Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Divergent Regulation of OCT and MATE Drug Transporters by Cadmium Exposure. | Pharmaceutics | 2021 | 33924306 | PubTator, text mining | PubMed |
| Sex-Biased lncRNA Signature in Fetal Growth Restriction (FGR). | Cells | 2021 | 33923632 | PubTator, text mining | PubMed |
| Membrane Carriers and Transporters in Kidney Physiology and Disease. | Biomedicines | 2021 | 33919957 | PubTator, text mining | PubMed |
| Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level. | Int J Mol Sci | 2021 | 33916769 | PubTator, text mining | PubMed |
| Nephrotoxicity of Anti-Angiogenic Therapies. | Diagnostics (Basel) | 2021 | 33916159 | PubTator, text mining | PubMed |
| Drug-drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H3 receptor antagonist. | Xenobiotica | 2021 | 33910470 | PubTator, text mining | PubMed |
| Comparisons of segment-specific toxicity of platinum-based agents and cadmium using S1, S2, and S3 cells derived from mouse kidney proximal tubules. | Toxicol In Vitro | 2021 | 33905841 | PubTator, text mining | PubMed |
| Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV. | AIDS Behav | 2021 | 33903997 | PubTator, text mining | PubMed |
| Exploring the molecular structure, vibrational spectroscopic, quantum chemical calculation and molecular docking studies of curcumin: A potential PI3K/AKT uptake inhibitor. | Heliyon | 2021 | 33898809 | PubTator, text mining | PubMed |
| Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced in vitro testing. | Expert Opin Drug Metab Toxicol | 2021 | 33896325 | PubTator, text mining | PubMed |
| A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients. | J Clin Pharmacol | 2021 | 33894017 | PubTator, text mining | PubMed |
| Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape. | Front Immunol | 2021 | 33868274 | PubTator, text mining | PubMed |
| Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies. | CNS Drugs | 2021 | 33866523 | PubTator, text mining | PubMed |
α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters. | Neuropharmacology | 2021 | 33864800 | PubTator, text mining | PubMed |
| Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine. | Clin Pharmacokinet | 2021 | 33830459 | PubTator, text mining | PubMed |
| PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction. | CPT Pharmacometrics Syst Pharmacol | 2021 | 33822485 | PubTator, text mining | PubMed |
| Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. | Cancers (Basel) | 2021 | 33805488 | PubTator, text mining | PubMed |
Antidiabetic and Renoprotective Effects of Coffea arabica Pulp Aqueous Extract through Preserving Organic Cation Transport System Mediated Oxidative Stress Pathway in Experimental Type 2 Diabetic Rats. | Molecules | 2021 | 33800673 | PubTator, text mining | PubMed |
| Systematic prediction of drug resistance caused by transporter genes in cancer cells. | Sci Rep | 2021 | 33795761 | PubTator, text mining | PubMed |
| Clinical pharmacology strategies in supporting drug development and approval of antibody-drug conjugates in oncology. | Cancer Chemother Pharmacol | 2021 | 33792763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=41